Literature DB >> 35657690

Cross Talk Between Insulin and Glucagon Receptor Signaling in the Hepatocyte.

Kirk M Habegger.   

Abstract

While the consumption of external energy (i.e., feeding) is essential to life, this action induces a temporary disturbance of homeostasis in an animal. A primary example of this effect is found in the regulation of glycemia. In the fasted state, stored energy is released to maintain physiological glycemic levels. Liver glycogen is liberated to glucose, glycerol and (glucogenic) amino acids are used to build new glucose molecules (i.e., gluconeogenesis), and fatty acids are oxidized to fuel long-term energetic demands. This regulation is driven primarily by the counterregulatory hormones epinephrine, growth hormone, cortisol, and glucagon. Conversely, feeding induces a rapid influx of diverse nutrients, including glucose, that disrupt homeostasis. Consistently, a host of hormonal and neural systems under the coordination of insulin are engaged in the transition from fasting to prandial states to reduce this disruption. The ultimate action of these systems is to appropriately store the newly acquired energy and to return to the homeostatic norm. Thus, at first glance it is tempting to assume that glucagon is solely antagonistic regarding the anabolic effects of insulin. We have been intrigued by the role of glucagon in the prandial transition and have attempted to delineate its role as beneficial or inhibitory to glycemic control. The following review highlights this long-known yet poorly understood hormone.
© 2022 by the American Diabetes Association.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35657690      PMCID: PMC9450567          DOI: 10.2337/dbi22-0002

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.337


  118 in total

1.  Insulinotropic glucagon-like peptide I receptor expression in glucagon-producing alpha-cells of the rat endocrine pancreas.

Authors:  R S Heller; T J Kieffer; J F Habener
Journal:  Diabetes       Date:  1997-05       Impact factor: 9.461

Review 2.  Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover.

Authors:  Roger H Unger; Alan D Cherrington
Journal:  J Clin Invest       Date:  2012-01-03       Impact factor: 14.808

3.  Mechanism of sympathetic neural regulation of insulin, somatostatin, and glucagon secretion.

Authors:  T Kurose; Y Seino; S Nishi; K Tsuji; T Taminato; K Tsuda; H Imura
Journal:  Am J Physiol       Date:  1990-01

Review 4.  The role of alpha-cell dysregulation in fasting and postprandial hyperglycemia in type 2 diabetes and therapeutic implications.

Authors:  Beth Elaine Dunning; John E Gerich
Journal:  Endocr Rev       Date:  2007-04-04       Impact factor: 19.871

5.  Perivenous localization of insulin receptor protein in rat liver, and regulation of its expression by glucose and oxygen in hepatocyte cultures.

Authors:  A Krones; T Kietzmann; K Jungermann
Journal:  Biochem J       Date:  2000-06-01       Impact factor: 3.857

6.  Cloning and sequence analysis of the murine glucagon receptor-encoding gene.

Authors:  R Burcelin; J Li; M J Charron
Journal:  Gene       Date:  1995-10-27       Impact factor: 3.688

7.  Single and multiple ascending-dose study of glucagon-receptor antagonist RN909 in type 2 diabetes: a phase 1, randomized, double-blind, placebo-controlled trial.

Authors:  Barry Gumbiner; Brooke Esteves; Vanessa Dell; Tenshang Joh; Pamela D Garzone; Alison Forgie; Chandrasekhar Udata
Journal:  Endocrine       Date:  2018-09-10       Impact factor: 3.633

Review 8.  Altered islet prohormone processing: a cause or consequence of diabetes?

Authors:  Adam Ramzy; Timothy J Kieffer
Journal:  Physiol Rev       Date:  2021-07-19       Impact factor: 37.312

9.  Exogenous glucose-dependent insulinotropic polypeptide worsens post prandial hyperglycemia in type 2 diabetes.

Authors:  Chee W Chia; Olga D Carlson; Wook Kim; Yu-Kyong Shin; Cornelia P Charles; Hee Seung Kim; Denise L Melvin; Josephine M Egan
Journal:  Diabetes       Date:  2009-03-10       Impact factor: 9.461

Review 10.  Brain control of insulin and glucagon secretion.

Authors:  Mayowa A Osundiji; Mark L Evans
Journal:  Endocrinol Metab Clin North Am       Date:  2012-12-21       Impact factor: 4.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.